Xinjiang Hengrun Industrial Co., Ltd is a branch of Xinjiang Huachun Investment Group, established in November 1996 with registered capital of 88905.5 thousand Yuan. The artificial person is Li Chenggong. The company has been awarded non-governmental scientific and technological enterprise and key protected enterprise of the autonomy district, AA+ level creditable enterprise awarded by China Industrial and Commercial Bank, Branch Xinjiang Uygur Autonomous District, AAA level creditable enterprise appraised by agricultural bank.
    Since the establishment, they have kept strengthening the force of research, development and investment to high-tech medical industry and have gained several great achievement in science and technology.
   ‘Snow lotus Yikangning’ is an A level new drug, invested and developed by the company, which was ranked as key local scientific and technologic project in the problem tackling plan of the country by State Administration of Science and Technology on May 4, 1999. Cooperating with Life Science and Engineering Academy under Tsinghua University, the company has successful in manufacturing YL-130, new antidepressant of Category II of state level. The company always regards high-tech research and development as the target, taking an active participation into the grand exploitation in the west and devoting actively into the construction of Huanchun-Tianshan Mountain pharmaceutical valley and the high-tech park of biological engineering.
   Through intensive management and circulative development of over 8 years, Xinjiang Hengrun Industrial Co., Ltd has developed into a comprehensive multi-industry and multi-region company that giving priority to biological pharmaceutics research and development, real estate development, comprehensive agricultural development, domestic and foreign trade, and so forth.